articleNatureAug 30, 2016Closed access

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

JSJeff SevignyPCPing ChiaoTBThierry BussièrePHPaul H. WeinrebLJLeslie J. Williams

Biogen (United States) · Neurotune (Switzerland) · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

3,042
total citations
FWCI
158.46
Percentile
100%
References
42
Citations per year

Authors

28

Topics & keywords

Topics
Keywords
  • Neurodegeneration
  • Monoclonal antibody
  • Neurotoxicity
  • Tolerability
  • Amyloid (mycology)
  • Medicine
  • Dementia
  • Humanized antibody
No related works found for this paper.

Funding